~~<i id='8D3E4C6925'><strike id='8D3E4C6925'><tt id='8D3E4C6925'><pre id='8D3E4C6925'></pre></tt></strike></i>~~

Home» leisure time» hotspot

hotspot

author：explore 2025-10-04 09:05:53 Page View：773

Venture capitalist Alexis Borisy Vanessa Leroy for STAT

EQRx is done, sold for its cash.

The once-buzzy but now dormant biotech company is being acquired by Revolution Medicines, a developer of cancer drugs, the companies announced Tuesday.

The all-stock deal is essentially a balance-sheet transfer of $1 billion in cash from EQRx to Revolution. What was left of EQRx’s drug pipeline is being shelved.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED Log In

Previous article： Readout Newsletter: Ozempic panic wanes, Legend x Novartis, etc.
Next article： United colonoscopy coverage change 'may cost lives,' doctors say

knowledge

After affirmative action ruling, medical educators look to 'holistic review'

AnnaMoneymaker/GettyImagesAfterhavingadaytoreadthroughtheSupremeCourt’sdecisiononaffirmativeaction,s

Why are Kaiser Permanente staff considering a strike?

Morethan75,000KaiserPermanentehealthcareworkershavevotedtoauthorizeastrikeifthetwosidescan'treachade

New air purifier tech could be key to improving indoor air quality

AdobeUntiltheearly20thcentury,Americaregularlyexperiencedbrutallydestructiveurbanfires.Conflagration

FDA reorg will put new emphasis on investigations, sources say

SarahSilbiger/GettyImagesWASHINGTON—There’sabouttobeanewacronymintown.TheFoodandDrugAdministrationis